Broadcasting News

"Why Did I Do That?" Apartment He Sold Rises 500 Million Won… Heo Kyung-hwan: "I Don't Own a Home"

"I Moved into a Jeonse Rental and Am Now a Non-Homeowner" Confession in a Real Estate Tour YouTube Video

KIM HYUNSIK
2026-07-18 13:41:12
[Edaily Starin KIM HYUNSIK Reporter] Comedian Heo Kyung-hwan opened up about how he regretted selling his house.
(Photo: Heo Kyung-hwan’s YouTube)
(Photo: Heo Kyung-hwan’s YouTube)
On the 16th, Heo Kyung-hwan posted a video titled “Heo Kyung-hwan’s Hannam-dong Real Estate Tour: Can I Buy My Own Home?” on his YouTube channel.
In the video, he said, “Three years ago, I sold an apartment near Gangnam-gu Office Station. I had lived there for about eight years, but I moved into my current home on a jeonse lease because I wanted a ‘Han River view.’” He added, “But after just three years, I found out that apartment’s value had risen by over 500 million won. I’m really shocked and angry.”
Heo Kyung-hwan also expressed regret at having missed an investment opportunity in the Hannam-dong redevelopment project. “I thought it would take a long time for the redevelopment to happen,” he said. “But one day, I saw they were already tearing down the housing complex. I was completely overwhelmed.”
Heo Kyung-hwan lamented, “I was interested in real estate investment, but I didn’t want to worry about it for a while, so I chose a jeonse lease with the mindset of ‘let’s take some time to think.’ But while I was thinking, so many things happened, and I couldn’t keep up.”
He reiterated, “I’m a non-homeowner living in a jeonse rental,” adding, “There’s a rumor that I have a lot of money, but that’s not my money—it’s the company’s money. I want to make it clear that I’m still not in a position to buy a house right now.”

Economy

Corporation

IT·Science

Economy

"Semiconductors Competing on the Global Stage… R&D Needs Relaxation of the '52-Hour Workweek Rule'"

“Regulations on the 52-hour workweek should be relaxed for businesses that create new concepts or for semiconductor research and development (R&D).”KoreaInformation&Communication Technology Promotion …
2026-08-13 19:30:52

Corporation

Injenia’s Enterprise Value Set to Grow Further After Listing… Backed by Three Major Positive Factors, Including Technology Exports

Ingenia Therapeutics (hereinafter “Ingenia”), a developer of new antibody drugs for microvascular diseases set to list on the KOSDAQ market on the 18th, is expected to show steep growth following a re…
2026-08-14 08:31:02

IT·Science

Royvant Bets on Hanol’s IMVT-1402… “GD New Drug to Launch Ahead of Competitors”

Royvant is focusing its funding and development capabilities on IMVT-1402 (active ingredient: imeropruvate), a next-generation FcRn antibody licensed from HANALL BIOPHARMA CO.,LTD(009420). This comes …
2026-08-14 08:36:02